| Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults (NCT05163847) | FluGen Inc | 2022-06-14 |
| A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food (NCT05337592) | Boehringer Ingelheim | 2022-06-14 |
| Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers (NCT05467696) | Concert Pharmaceuticals | 2022-06-14 |
| A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants (NCT05418868) | ViiV Healthcare | 2022-06-14 |
| Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations. (NCT05488821) | Qilu Pharmaceutical Co., Ltd. | 2022-06-14 |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| A Study of AG-80308 in Dry Eye Patients (NCT05372107) | Allgenesis Biotherapeutics Inc. | 2022-06-13 |
| Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma (NCT05433142) | Xencor, Inc. | 2022-06-13 |
| Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells (NCT05155657) | Yantai Yuhuangding Hospital | 2022-06-13 |
| Clinical Study of Allergic Rhinitis Therapy by Stem Cells (NCT05151133) | Yantai Yuhuangding Hospital | 2022-06-13 |
| A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard (NCT05402111) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-06-13 |
| Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC) (NCT05422781) | Immunomic Therapeutics, Inc. | 2022-06-13 |
| Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers (NCT05438303) | AstraZeneca | 2022-06-13 |
| Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC (NCT05265650) | Clinica Universidad de Navarra, Universidad de Navarra | 2022-06-13 |
| Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL (NCT05233033) | Kymera Therapeutics, Inc. | 2022-06-13 |
| Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers (NCT05713188) | MediSieve Limited | 2022-06-13 |
| Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP) (NCT05452174) | Northwestern University | 2022-06-13 |
| BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL (NCT05370430) | PeproMene Bio, Inc. | 2022-06-13 |
| Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma (NCT05412329) | Shanghai Changzheng Hospital | 2022-06-13 |
| Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid) (NCT06180057) | Humanis Saglık Anonim Sirketi | 2022-06-12 |
| A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors (NCT05216965) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-06-11 |
| A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers (NCT05363384) | Celltrion | 2022-06-11 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD (NCT05003947) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-06-11 |
| A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 (NCT05164133) | Hoffmann-La Roche | 2022-06-10 |
| A Study of NP-011 in Healthy Volunteers (NCT05387499) | Nexel Co., Ltd. | 2022-06-10 |
| A Study of RGLS8429 in Healthy Volunteers (NCT05429073) | Regulus Therapeutics Inc. | 2022-06-10 |
| A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants (NCT05431153) | Pfizer | 2022-06-10 |
| Regeneration of Knee and Ankle Cartilage From Autologous Cartilage Mini-grafts (From the Patient's Own Cells) (NCT06897098) | Vanarix SA | 2022-06-10 |
| A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) (NCT04941404) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-10 |
| GPC3-CAR-T Cells for the Hepatocellular Carcinoma (NCT04506983) | Beijing Tsinghua Chang Gung Hospital | 2022-06-10 |
| A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103) (NCT05567354) | Ensysce Biosciences | 2022-06-10 |
| Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients (NCT05349968) | Shanxi Kangbao Biological Product Co., Ltd. | 2022-06-10 |
| Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis (NCT05342428) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2022-06-10 |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis (NCT05119140) | Icahn School of Medicine at Mount Sinai | 2022-06-10 |
| Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma (NCT05398198) | GlaxoSmithKline | 2022-06-09 |
| Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib (NCT05280509) | Telios Pharma, Inc. | 2022-06-09 |
| A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) (NCT05384626) | Nuvalent Inc. | 2022-06-09 |
| Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older (NCT05426174) | Sanofi Pasteur, a Sanofi Company | 2022-06-09 |
| Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210) | Fred Hutchinson Cancer Center | 2022-06-09 |
| A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005) (NCT05347225) | Merck Sharp & Dohme LLC | 2022-06-09 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults (NCT05351086) | Pulmatrix Inc. | 2022-06-09 |
| A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People (NCT05411588) | Pfizer | 2022-06-09 |
| Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts (NCT05415241) | Ruijin Hospital | 2022-06-09 |
| Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects (NCT05518695) | Bio-Thera Solutions | 2022-06-09 |
| Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion (NCT05245500) | Bristol-Myers Squibb | 2022-06-09 |
| An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid Malignancies (NCT05469919) | AstraZeneca | 2022-06-09 |
| Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women (NCT04900974) | University of North Carolina, Chapel Hill | 2022-06-09 |
| A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants (NCT05389722) | Bristol-Myers Squibb | 2022-06-09 |
| To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma (NCT05400876) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-09 |
| An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition (NCT05390944) | Impact Therapeutics, Inc. | 2022-06-08 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects (NCT04711343) | Bio-Thera Solutions | 2022-06-08 |
| A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (NCT05395481) | Eli Lilly and Company | 2022-06-08 |
| GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites (NCT05438459) | Kyushu University | 2022-06-08 |
| Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma (NCT05351593) | James Rubenstein | 2022-06-08 |
| A First-in-Human Study of QY101 Ointment in Adult Subjects (NCT05429177) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2022-06-08 |
| A Study of ASP3082 in Adults With Advanced Solid Tumors (NCT05382559) | Astellas Pharma Inc | 2022-06-08 |
| First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects (NCT05427253) | Vicore Pharma AB | 2022-06-08 |
| To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer (NCT05969314) | Tata Memorial Hospital | 2022-06-08 |
| Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. (NCT05462379) | MARILIA ALBANEZI BERTOLAZZI | 2022-06-08 |
| First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants (NCT05366764) | Sanofi | 2022-06-08 |
| Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation (NCT05005299) | Melbourne Health | 2022-06-08 |
| A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors (NCT05378178) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-06-08 |
| Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors (NCT05538195) | Chongqing Precision Biotech Co., Ltd | 2022-06-07 |
| Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers (NCT05095337) | Jiangsu HengRui Medicine Co., Ltd. | 2022-06-07 |
| A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants (NCT05378906) | Janssen Research & Development, LLC | 2022-06-07 |
| A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer (NCT05365581) | Astellas Pharma Global Development, Inc. | 2022-06-07 |
| A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors (NCT05205109) | Antengene Therapeutics Limited | 2022-06-07 |
| Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma (NCT05373901) | BeiGene | 2022-06-07 |
| A Study of Topical XG004 in Participants With Osteoarthritis of the Knee (NCT05454020) | Xgene Pharmaceutical Group | 2022-06-07 |
| Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors (NCT05441046) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2022-06-07 |
| A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab (NCT05175352) | Celgene | 2022-06-07 |
| A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus (NCT05407961) | Eli Lilly and Company | 2022-06-07 |
| Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults (NCT05547399) | BeiGene | 2022-06-07 |
| A Study of KL340399 in Patients With Advanced Solid Tumors (NCT05387928) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-06-07 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers (NCT05364840) | Sorrento Therapeutics, Inc. | 2022-06-07 |
| A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours (NCT05397171) | AstraZeneca | 2022-06-07 |
| Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) (NCT05396833) | EMD Serono Research & Development Institute, Inc. | 2022-06-07 |
| A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease (NCT05331300) | Lassen Therapeutics 1 PTY LTD | 2022-06-06 |
| A First in Human Study of ORT247 in Healthy Volunteers (NCT06769620) | Orthogonal Neuroscience Inc. | 2022-06-06 |
| A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers (NCT05397041) | Bright Minds Biosciences Pty Ltd | 2022-06-06 |
| Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy (NCT05394740) | National Cancer Center Hospital East | 2022-06-06 |
| Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects (NCT04520217) | Wright State University | 2022-06-06 |
| A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer (NCT05412225) | Memorial Sloan Kettering Cancer Center | 2022-06-06 |
| An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition (NCT05391048) | Impact Therapeutics, Inc. | 2022-06-06 |
| Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543 (NCT05468749) | Concert Pharmaceuticals | 2022-06-06 |
| Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole (NCT05631678) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2022-06-06 |
| Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia (NCT05320198) | Disc Medicine, Inc | 2022-06-06 |
| A Study of TFX05-01 in Patients With Advanced Solid Tumors (NCT05434299) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2022-06-05 |
| The Effect of Vitamin D3 Therapy in Post Menopausal Women and Assessment of Changes in Bone Mineral Density After Orally Vitamin D3 Administration (NCT05389943) | University of Sargodha | 2022-06-05 |
| Neuroprotective Effect of Dexomitomidine (NCT05487742) | Tanta University | 2022-06-04 |
| Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank (NCT04975347) | Stephanie B. Seminara, MD | 2022-06-03 |
| Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp (NCT05456854) | Massachusetts General Hospital | 2022-06-03 |
| Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141 (NCT05652595) | Geropharm | 2022-06-03 |
| Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors (NCT05367778) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-06-03 |
| HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors (NCT05360381) | Shanghai Henlius Biotech | 2022-06-03 |
| Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency (NCT05222178) | Homology Medicines, Inc | 2022-06-03 |
| IMM-BCP-01 in Mild to Moderate COVID-19 (NCT05429021) | Immunome, Inc. | 2022-06-03 |
| A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (NCT05428969) | Faron Pharmaceuticals Ltd | 2022-06-02 |
| Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. (NCT05490108) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-06-02 |
| Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity (NCT05382767) | CKD Bio Corporation | 2022-06-02 |